生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Naftopidil (Dihydrochloride), a selective α1-adrenergic receptor antagonist or alpha blocker, is an antihypertensive drug. Naftopidil significantly improved the overall international prostatic symptom score[3]. The intravenous administration of each of Naftopidil dose-dependently inhibited phenylephrine-induced increases in prostatic pressure and mean blood pressure, the selectivity index was 3.76 [4]. Moreover, Naftopidil induces apoptosis and autophagy of HGC27 cells (human gastric cancer cell line), however, autophagy is considered to inhibit apoptosis[5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.15mL 0.43mL 0.21mL |
10.74mL 2.15mL 1.07mL |
21.49mL 4.30mL 2.15mL |
参考文献 |
---|